Advanced Search

 

Study ID Status Title Patient Level Data
SUMA4016 Completed A Randomized, Double-Blind, Double-Dummy, Active-Placebo Controlled, Parallel Group Evaluation of Oral Sumatriptan (50mg) Compared to Oral Naproxen Sodium (275mg) on Migraine-Related Quality of Life.
SUMA4017 Completed A Randomized, Double-Blind, Double-Dummy, Active-Placebo Controlled, Parallel Group Evaluation of Oral Sumatriptan (50mg) Compared to Oral Naproxen Sodium (275mg) on Migraine-Related Quality of Life.
SUMAI 01 Completed An open 6-month-study for the treatment of acute migraine attacks with sumatriptan (6 mg subcutaneous (sc). plus optional 6 mg sc) using an autoinjector, complemented by a) the possibility to prolong the study up to 18 months in total; and/or complemented by b) the possibility to assess quality ...
SUMAI CH Completed An open 12-month study for the acute treatment of cluster headache attacks with sumatriptan using an autoinjector.
SUMB1006 Completed An open, uncontrolled study to investigate the single dose pharmacokinetics of sumatriptan nasal spray in adolescent subjects with migraine outside of a migraine attack.
SUMB2001 Completed A double-blind, randomised, placebo-controlled study to investigate the neuroendocrine response to repeat-dose oral sumatriptan in adolescent migraineurs.
SUMB2003 Completed A double-blind, randomised, placebo-controlled study to compare the efficacy and safety of oral sumatriptan (25mg, 50mg and 100mg) in the acute treatment of migraine in adolescents.
SUMB3002 Completed A double-blind, placebo-controlled, parallel-group study to evaluate two dose levels (10mg and 20mg) of sumatriptan nasal spray in the acute treatment of a migraine attack with an optional repeat dose for headache recurrence.
SUMB3005 Completed An open-label study to evaluate repeat-dose oral sumatriptan 100mg in the acute treatment of adolescent migraine during a six month period.
SUMB4002 Completed A double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety and tolerability of a 6mg sc dose of sumatriptan in patients who have not responded to acute treatment of a migraine attack with 100mg oral dose of sumatriptan.
SUMB4007 Completed A double-blind, parallel group study to compare the benefits of 100mg and 50mg oral sumatriptan in patients dissatisfied with the relief of their migraine symptoms following open-label treatment with 50mg oral sumatriptan.
SUMT40 Completed A crossover study to evaluate the efficacy and tolerability between sumatriptan suppository 25mg and sumatriptan tablet 50mg in the treatment of acute migraine (with and without aura) associated with the menstrual cycle.
SX12003 Completed Treatment of depressed and/or anxiety subjects with paroxetine in the primary care.
T3157503 Completed Comparison of the clinical efficacy from the retention phase of fluoride delivery of fluoride toothpastes using an in situ caries model
T3500690 Completed Comparison of enamel remineralization potential of dentifrices incorporating different fluoride salts using an in situ caries model
T3508565 Completed Clinical efficacy of fluoride toothpastes using an in situ caries model
T3508570 Completed Evaluation of plaque fluid fluoride retention from fluoride toothpastes
T3508605 Completed Clinical efficacy of fluoride toothpastes using an in situ caries model
Taiwan-PAR Completed Paroxetine in the Treatment of Chinese Patients with Depressive Episodes – A Double-blind randomized Comparison with Imipramine
TDR3088 Completed Safety, pharmacokinetics and pharmacodynamics (PD) of Org31540/SR90107A after repeated intravenous injection in healthy male volunteers
TDU3085 Completed Safety and pharmacokinetics of ORG31540/SR90107A after a single intravenous injection in healthy male volunteers
TDU3166 Completed A study to investigate the safety, pharmacokinetics and pharmacodynamics (PD) of ORG31540/SR90107A administered as a single intravenous drip to healthy male volunteers
TDU4089 Completed A safety, pharmacokinetics and bioavailability study after single dose subcutaneous administration of Org31540/SR90107A 0.75, 2.5, and 8mg in young adult Japanese healthy male subjects.
TDU4289 Completed A safety and pharmacokinetics study after single dose subcutaneous administration of Org31540/SR90107A 2.5mg in elderly Japanese healthy male volunteers.
THRS/79/0010 (Well 18) Completed Examination of bupropion and diazepam, alone and in combination on human performance tests, subjective rating scales, EEG and autonomic responses.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.